Skip to main content
The Egyptian Journal of Bronchology
Fig. 1 | The Egyptian Journal of Bronchology

Fig. 1

From: Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer

Fig. 1

Kaplan-Meier curve for OS in patients who received sequential therapy with osimertinib, who received re-administration of the first-/second-generation EGFR-TKIs, and who received neither of the above. Solid line: the patient group that received sequential therapy with osimertinib; dotted line: the patient group that received re-administration of first-/second-generation EGFR-TKIs; dashed line: patients who received neither sequential therapy with osimertinib nor re-administration of first-/second-generation EGFR-TKIs

Back to article page